SGLT2 抑制剂和复杂的尿路感染:一种罕见的肺炎病例和与达帕格利弗洛辛使用相关的后续复发
Harveen Kaur1,2, Shaylika Chauhan3, Manajyoti Yadav2
1Department of Internal Medicine University of Chicago Medical Center Chicago Illinois USA.
Clinical case reports
|October 20, 2025
概括
临床医生在开处方达帕格利弗洛辛 (一种-葡萄糖共运输体-2抑制剂) 时应谨慎,因为可能增加严重尿路感染 (UTI) 的风险. 一个案例研究强调了服用这种药物的患者的复发性肺炎.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
背景情况:
- -葡萄糖共载体-2 (SGLT2) 抑制剂通常用于2型糖尿病.
- 尿路感染 (UTI) 是SGLT2抑制剂已知的潜在副作用之一.
- 腹膜性皮叶龙炎是一种罕见但严重的尿路感染并发症.
研究的目的:
- 报告患有严重和复发性肺炎的病例,该病例发生在接受达帕格利弗洛辛治疗的患者中.
- 要突出达帕格利弗洛辛使用和复杂的尿路感染之间的潜在关联.
主要方法:
- 案例报告的呈现方式.
- 审查患者的病史和药物治疗.
- 在药物重新挑战后感染复发的临床观察.
主要成果:
- 一个没有先前尿路感染病史的患者在服用达帕格利弗洛辛时患上了血栓塞发性皮叶龙炎.
- 患者在恢复达帕格利弗洛辛治疗后出现了复发性炎症.
- 这表明达帕格利弗洛辛与严重尿路感染之间存在潜在联系.
结论:
- 达帕格利弗洛辛可能会增加严重和复杂的尿路感染的风险.
- 临床医生在开处方达帕格利弗洛辛时应谨慎,特别是在患有尿路感染风险因素的患者中.
- 需要进一步研究SGLT2抑制剂相关复杂性尿路感染的机制和发病率.
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
581
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
581
Urinary Tract Infection I: Introduction
531
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
531
Acute Pyelonephritis II: Diagnostic Studies and Management
308
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
308
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
250
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
250
Urinary Tract Infection II: Pathophysiology
563
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
563
Acute Pyelonephritis I: Introduction
475
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
475


